Please login to the form below

Not currently logged in
Email:
Password:

Sativex

This page shows the latest Sativex news and features for those working in and with pharma, biotech and healthcare.

GW Pharma’s Epidyolex gets EU approval for severe epilepsy

GW Pharma’s Epidyolex gets EU approval for severe epilepsy

The first CBD-based medicine to reach the market in Europe was GW Pharma’s Sativex, an oromucosal spray formulation that is approved to treat moderate to severe spasticity in multiple

Latest news

More from news
Approximately 4 fully matching, plus 59 partially matching documents found.

Latest Intelligence

  • Death by Numbers Death by Numbers

    Not so. Take the example of this campaign for Sativex, a drug used in the treatment of Multiple Sclerosis. ... The obvious solution to the brief was an ingredient story - Sativex is derived from cannabis.

  • Interview: Jorge Gallardo, Almirall Interview: Jorge Gallardo, Almirall

    Also in 2011, we have launched Sativex,  an oral spray for spasticity in multiple sclerosis, which will be deployed in Europe soon.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • GW hires Pfizer’s Kenneth Sommerville GW hires Pfizer’s Kenneth Sommerville

    GW's research is focused on the development of cannabinoids. This includes Sativex, which became the world's first plant-derived cannabinoid prescription drug when it was approved for multiple sclerosis ... This is an exciting time to be joining GW, with

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...
What is changing in cardiovascular disease care?
Paul Midgley, of Wilmington Healthcare, explores the NHS Long-term Plan’s strategy for tackling cardiovascular disease and what it means for pharma...

Infographics